Diabetes treatment – more good results
After one year of Phase III trials, Type 1 diabetes patients receiving Diapep 277 from Israel’s Andromeda Biotech, had significantly improved pancreatic performance. In the expanded trials, 450 patients were involved, from 120 medical centres across the world.
42 countries to attend ILSI BioMed expo
(thanks to Israel21c) Thousands of top Israeli and international business executives, decision makers, and leading researchers, will participate in Tel Aviv’s annual expo that is known for highlighting the bio-medical industry’s latest innovations and technologies.
The gene that blocks the intestines
(thanks to Israel21c) A research team from Ben-Gurion University has discovered genetic mutations that lead to intestinal blockages in newborns from two Bedouin tribes in Israel. To date, the team has discovered the genetic mutations leading to more than 20 diseases in human beings.
Immune response to melanoma
Israeli oncology treatment developer cCam Medical Ltd has developed CM-10, an immune-modulating antibody, whose anticancer effect has been demonstrated in multiple pre-clinical tests. cCam has just raised $3million to fund further trials.
Come to Israel for treatment
As medical costs continue to rise in the United States, both those seeking treatment and the companies that insure them are feverishly looking for ways to cut costs. One of those ways is to “export” treatment — to send patients abroad to countries where treatment is cheaper. Among those destinations is Israel, with some 30,000 patients coming here annually to take advantage of treatments.
First Israeli artificial heart transplant
Doctors at the Rabin Medical Center - Beilinson Campus in Petah Tikva transplanted a totally artificial heart into a 63-year-old man suffering from severe cardiac insufficiency and organ failure. Israeli surgeons normally use artificial hearts as a bridge to a patient’s existing heart, however in this case the patient’s own heart would have been unable to survive the operation.
MS patients benefit from Israeli drug switch
Multiple Sclerosis patients who switched to Teva’s Copaxone from interferon-beta treatment showed a significant reduction in spasticity. In addition, interim results for the first 52 of 110 participants of Teva’s study revealed much reduced muscle stiffness, pain and discomfort.
Israel’s helps asthmatics breathe easier
(Thanks to Israel21c) On World Asthma Day, here are the top 10 Israeli innovations to help prevent, diagnose, monitor and treat the chronic disease.
Gaucher’s drug approved
(Thanks to Israel21c and Globes) Elelyso – a new treatment for Gaucher’s disease, from Israel’s Protalix BioTherapeutics, is set to hit pharmacies around the globe, following approval by the American Food and Drug Administration. The drug has been licensed to Pfizer.
Israeli surgeons save pregnant Cypriot woman
In a 48-hour operation, doctors at Jerusalem’s Hadassah hospital saved the life of a 30-year old woman from Cyprus suffering from an ectopic pregnancy. Her non-viable foetus was discovered behind a kidney and had already damaged blood vessels, causing major bleeding.